IP Library Granted Patent US 7,576,052
Granted Patent B2
US 7,576,052 · App. 10/968,791 · Granted Aug 18, 2009

Methods and compositions for modulating adipocyte function

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,576,052
App. No.
10/968,791
Granted
Aug 18, 2009
Kind
B2
Abstract

Methods and compositions for treating obesity and related disorders. The methods include the use of BMP-2, -4, -6 and -7.

Claims (26)

1. A method of promoting brown adipocyte tissue (BAT) differentiation, the method comprising:

contacting a preadipocyte or adipocyte cell or tissue in vitro with a composition comprising a bone morphogenetic protein 7 (BMP-7) polypeptide, in an amount sufficient to promote BAT differentiation, thereby producing a differentiated cell or tissue; and

evaluating BAT differentiation in the differentiated cell or tissue by measuring uncoupling protein-1 expression, wherein an increase in uncoupling protein-1 expression indicates an increase in BAT differentiation.

2. The method of claim 1 , wherein the cell or tissue comprises a brown preadipocyte.

3. The method of claim 1 , wherein the cell or tissue comprises a white preadipocyte or white adipocyte.

4. The method of claim 1 , wherein the cell or tissue is in culture.

5. The method of claim 4 , wherein the cell or tissue is isolated from a living subject.

6. The method of claim 5 , wherein the living subject is an obese human subject.

7. A method of decreasing fat stores or weight in a subject, the method comprising identifying a subject in need of decreasing fat stores or weight, and administering to the subject a therapeutically effective amount of a composition consisting essentially of a bone morphogenetic protein 7 (BMP-7) polypeptide.

8. The method of claim 1 , where the BMP-7 polypeptide comprises amino acids 293-431 of SEQ ID NO:5.

9. The method of claim 7 , where the BMP-7 polypeptide comprises amino acids 293-431 of SEQ ID NO:5.

10. The method of claim 1 , wherein the level of BAT differentiation is further evaluated by measuring the level of a marker of BAT differentiation selected from the group consisting of PPAR-gamma Coactivator 1 (PGC-1), cytochrome oxidase activity, and mitochondrial DNA levels, wherein an increase in the level of the BAT marker indicates an increase in BAT differentiation.

11. The method of claim 1 , wherein the level of BAT differentiation is further evaluated by measuring morphological changes specific to BAT.

12. The method of claim 1 , further comprising implanting the differentiated cell in a subject.

13. The method of claim 12 , wherein the subject is human.

14. A method for providing a cell culture enriched in brown adipocytes, the method comprising:

providing a plurality of preadipocyte or adipocyte cells in vitro;

contacting the plurality of cells with a composition comprising a bone morphogenetic protein 7 (BMP-7) polypeptide in an amount sufficient to promote BAT differentiation; and

evaluating BAT differentiation in the culture, by measuring uncoupling protein-1 expression, wherein an increase in uncoupling protein-1 expression indicates an increase in BAT differentiation, thereby providing a culture enriched in brown adipocytes.

15. The method of claim 14 , further comprising implanting at least one brown adipocyte from said enriched culture into a subject.

16. The method of claim 15 , wherein the subject is human.

17. The method of claim 14 , where the BMP-7 polypeptide comprises amino acids 293-431 of SEQ ID NO:5.

18. The method of claim 7 , wherein the composition is administered intramuscularly.

19. The method of claim 7 , wherein the composition is administered to a site of adipose tissue.

20. The method of claim 19 , wherein the site of adipose tissue is a subcutaneous or omentum adipose pad.

21. The method of claim 19 , where the BMP-7 polypeptide comprises amino acids 293-431 of SEQ ID NO:5.

Assignments (3)
CONFIRMATORY LICENSE Recorded May 2, 2008
From: JOSLIN DIABETES CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 020892/0640 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2005
From: KAHN, C. RONALD; TSENG, YU-HUA
To: JOSLIN DIABETES CENTER, INC.
Reel/Frame 016208/0906 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2005
From: BUTTE, ATUL
To: CHILDREN'S HOSPITAL BOSTON
Reel/Frame 016209/0004 →